Log In
Print
BCIQ
Print
Print this Print this
 

AZD5069

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionCXC chemokine receptor 2 (CXCR2) antagonist
Molecular Target CXC chemokine receptor 2 (CXCR2) (IL8RB)
Mechanism of ActionCXC chemokine receptor 2 (CXCR2) antagonist
Latest Stage of DevelopmentPhase II
IndicationChronic obstructive pulmonary disease (COPD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today